Dramatic genome-wide reprogramming of mRNA in hypometabolic muscle
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology · 2024-06 · 272 · 110952
DOI: 10.1016/j.cbpb.2024.110952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 2024-06. Verfasst von Nicholas J Hudson und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Agriculture and Food Sustainability, The University of Queensland, Gatton, Queensland 4343, Australia. Electronic address: n.hudson@uq.edu.…. Hauptthemen laut MEDLINE: Muscle, Skeletal, Anura. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council.
Abstract (Originalsprache)
In response to seasonal droughts, the green striped burrowing frog Cyclorana alboguttata enters a reversible hypometabolic state called aestivation where heart rate and oxygen consumption can be reduced despite warm (>25C°) ambient temperatures. With a view to understanding molecular mechanisms we profiled aestivating versus control gastrocnemius muscle using mRNA sequencing. This indicated an extensive metabolic reprogramming, with nearly a quarter of the entire transcriptome (3996 of 16,960 mRNA) exhibiting a nominal >2-fold change. Consistent with a physiological adaptation to spare carbohydrate reserves, carbohydrate catabolism was systemically downregulated. A 630-fold downregulation of ENO3 encoding the enolase enzyme was most striking. The 590 frog orthologs of mRNA encoding the mitoproteome were, viewed as a population, significantly downregulated during aestivation, although not to the same extent as mRNA encoding carbohydrate catabolism. Prominent examples include members of the TCA cycle (IDH2), electron transport chain (NDUFA6), the ATP synthase complex (ATP5F1B) and ADP/ATP intracellular transport (SLC25A4). Moreover, mRNA derived from the mt genome itself (e.g. mt-ND1) were also downregulated. Most prominent among the upregulated mRNA are those encoding aspects of regulated proteolysis including the proteosome (e.g. PSME4L), peptidases (USP25), atrogins (FBXO32) and ubiquitination (VCP). Finally, we note the ∼5-fold upregulation of the mRNA EIFG3 that encodes part of the EIF4F complex. This possesses global control of protein synthesis. Given protein synthesis is repressed in aestivating frogs this indicates the skeletal musculature is poised for accelerated translation of mRNA upon emergence, supporting a strategy to rapidly restore function when the summer rains come.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Agriculture and Food Sustainability, The University of Queensland, Gatton, Queensland 4343, Australia. Electronic address: n.hudson@uq.edu.au.
- School of the Environment, The University of Queensland, St. Lucia, Queensland 4072, Australia.
- School of the Environment, The University of Queensland, St. Lucia, Queensland 4072, Australia. Electronic address: https://twitter.com/Franklin_EcoLab.
Förderung
- Australian Research Council
Zitieren
APA
Hudson, N. J., Cramp, R. L., & Franklin, C. E. (2024). Dramatic genome-wide reprogramming of mRNA in hypometabolic muscle. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 272, 110952. https://doi.org/10.1016/j.cbpb.2024.110952
Vancouver
Hudson NJ, Cramp RL, Franklin CE. Dramatic genome-wide reprogramming of mRNA in hypometabolic muscle. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 2024;272:110952. doi:10.1016/j.cbpb.2024.110952
BibTeX
@article{Hudson2024,
author = {Hudson, Nicholas J and Cramp, Rebecca L and Franklin, Craig E},
title = {Dramatic genome-wide reprogramming of mRNA in hypometabolic muscle},
journal = {Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology},
year = {2024},
volume = {272},
pages = {110952},
doi = {10.1016/j.cbpb.2024.110952}
}
EUVIMED